MATTHEW HODGSON: Open Payments
NPI 1659809762 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $80 · 2025 $339
Food & beverage: $270Education: $68
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $85 |
| Janssen Biotech, Inc. | 2 | $63 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| BeOne Medicines USA, Inc. | 2 | $40 |
| Celgene Corporation | 1 | $26 |
| Novocure Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| JAZZ PHARMACEUTICALS INC. | 1 | $19 |
| Coherus Oncology, Inc. | 1 | $15 |
Products named: IMFINZI, TALVEY, KEYTRUDA, REBLOZYL, Optune Lua (NovoTTF-200T), Padcev, TEVIMBRA, BRUKINSA.
Industry payments across NY — which companies pay providers there.
